Btg Pactual Global Asset Management LTD Gilead Sciences, Inc. Transaction History

Btg Pactual Global Asset Management LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $331,774 - $373,677	-5,748 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $332,924 - $417,189	5,748 New	5,748 $342,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $676,401 - $770,727	-11,940 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $741,474 - $932,275	11,940 New	11,940 $754,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $190,398 - $248,455	-3,145 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $454,766 - $503,509	-6,380 Reduced 66.98%	3,145 $243,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $69,486 - $81,053	1,071 Added 12.67%	9,525 $675,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $38,386 - $46,797	-527 Reduced 5.87%	8,454 $637,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $21,629 - $25,390	304 Added 3.5%	8,981 $643,000
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $320,889 - $380,341	-4,450 Reduced 33.9%	8,677 $703,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,127	13,127 $929,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.